DexCom (NASDAQ: DXCM) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Texas residents who were exposed to greater levels of toxic metals were found to develop markers for type 2 diabetes earlier.